{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T20:24:23Z","timestamp":1794428663826,"version":"4.9.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":69,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-71895-x","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T11:22:36Z","timestamp":1776252156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Genome-wide CRISPR screens in primary human natural killer cells identify countermeasures against immunosuppressive environment"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3306-8370","authenticated-orcid":false,"given":"Quoc Viet","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jun","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason Cheng-Yu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8613-0700","authenticated-orcid":false,"given":"Hsin-An","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenifer","family":"Faustine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Chieh","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Yu","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Wen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsu-Lan","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7542-4663","authenticated-orcid":false,"given":"Steven","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"71895_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev.immunol.23.021704.115526","volume":"23","author":"LL Lanier","year":"2005","unstructured":"Lanier, L. L. NK cell recognition. Annu. Rev. Immunol. 23, 225\u2013274 (2005).","journal-title":"Annu. Rev. Immunol."},{"key":"71895_CR2","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/ni.3518","volume":"17","author":"C Guillerey","year":"2016","unstructured":"Guillerey, C., Huntington, N. D. & Smyth, M. J. Targeting natural killer cells in cancer immunotherapy. Nat. Immunol. 17, 1025\u20131036 (2016).","journal-title":"Nat. Immunol."},{"key":"71895_CR3","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/s41423-024-01207-0","volume":"21","author":"L Peng","year":"2024","unstructured":"Peng, L., Sferruzza, G., Yang, L., Zhou, L. & Chen, S. CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors. Cell. Mol. Immunol. 21, 1089\u20131108 (2024).","journal-title":"Cell. Mol. Immunol."},{"key":"71895_CR4","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ni.3470","volume":"17","author":"RB Delconte","year":"2016","unstructured":"Delconte, R. B. et al. CIS is a potent checkpoint in NK cell\u2013mediated tumor immunity. Nat. Immunol. 17, 816\u2013824 (2016).","journal-title":"Nat. Immunol."},{"key":"71895_CR5","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/s41587-024-02282-4","volume":"43","author":"L Peng","year":"2025","unstructured":"Peng, L. et al. In vivo AAV\u2013SB-CRISPR screens of tumor-infiltrating primary NK cells identify genetic checkpoints of CAR-NK therapy. Nat. Biotechnol. 43, 752\u2013761 (2025).","journal-title":"Nat. Biotechnol."},{"key":"71895_CR6","doi-asserted-by":"crossref","unstructured":"Kim, Y.-M., Akana, R. V., Sun, C., Laveroni, O. & Jerby, L. Redirecting cytotoxic lymphocytes to breast cancer tumors via metabolite-sensing receptors. bioRxiv 2025.03.21.644686 (2025).","DOI":"10.1101\/2025.03.21.644686"},{"key":"71895_CR7","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1016\/j.ccell.2025.05.011","volume":"43","author":"I Nikolic","year":"2025","unstructured":"Nikolic, I. et al. Enhancing anti-tumor immunity of natural killer cells through targeting IL-15R signaling. Cancer Cell 43, 2034\u20132050.e11 (2025).","journal-title":"Cancer Cell"},{"key":"71895_CR8","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1016\/j.ccell.2025.07.021","volume":"43","author":"A Biederst\u00e4dt","year":"2025","unstructured":"Biederst\u00e4dt, A. et al. Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency. Cancer Cell 43, 2069\u20132088 (2025).","journal-title":"Cancer Cell"},{"key":"71895_CR9","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1016\/j.cell.2018.10.024","volume":"175","author":"E Shifrut","year":"2018","unstructured":"Shifrut, E. et al. Genome-wide CRISPR screens in primary human T cells reveal key regulators of immune function. Cell 175, 1958\u20131971 (2018).","journal-title":"Cell"},{"key":"71895_CR10","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1182\/blood-2014-02-558163","volume":"124","author":"A Girard-Gagnepain","year":"2014","unstructured":"Girard-Gagnepain, A. et al. Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs. Blood 124, 1221\u20131231 (2014).","journal-title":"Blood"},{"key":"71895_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1006\/cimm.1996.0003","volume":"167","author":"JBD Sanctis","year":"1996","unstructured":"Sanctis, J. B. D., Blanca, I., Radzioch, D. & Bianco, N. E. Expression and function of low-density lipoprotein receptors in CD3\u2212CD16+CD56+cells: effect of interleukin 2. Cell. Immunol. 167, 18\u201329 (1996).","journal-title":"Cell. Immunol."},{"key":"71895_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2023.114689","volume":"314","author":"K Noguchi","year":"2023","unstructured":"Noguchi, K. et al. Protocol for a high titer of BaEV-Rless pseudotyped lentiviral vector: focus on syncytium formation and detachment. J. Virol. Methods 314, 114689 (2023).","journal-title":"J. Virol. Methods"},{"key":"71895_CR13","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1016\/j.celrep.2019.11.050","volume":"29","author":"DL Mallery","year":"2019","unstructured":"Mallery, D. L. et al. Cellular IP6 levels limit HIV production while viruses that cannot efficiently package IP6 are attenuated for infection and replication. Cell Rep. 29, 3983\u20133996.e4 (2019).","journal-title":"Cell Rep."},{"key":"71895_CR14","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","volume":"34","author":"JG Doench","year":"2016","unstructured":"Doench, J. G. et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat. Biotechnol. 34, 184\u2013191 (2016).","journal-title":"Nat. Biotechnol."},{"key":"71895_CR15","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1038\/onc.2015.407","volume":"35","author":"A-S Tigan","year":"2016","unstructured":"Tigan, A.-S., Bellutti, F., Kollmann, K., Tebb, G. & Sexl, V. CDK6\u2014a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation. Oncogene 35, 3083\u20133091 (2016).","journal-title":"Oncogene"},{"key":"71895_CR16","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.stem.2014.04.001","volume":"14","author":"A Tapias","year":"2014","unstructured":"Tapias, A. et al. Trrap-dependent histone acetylation specifically regulates cell-cycle gene transcription to control neural progenitor fate decisions. Cell Stem Cell 14, 632\u2013643 (2014).","journal-title":"Cell Stem Cell"},{"key":"71895_CR17","doi-asserted-by":"publisher","first-page":"6325","DOI":"10.1158\/0008-5472.CAN-10-0015","volume":"70","author":"D Peterson","year":"2010","unstructured":"Peterson, D. et al. A chemosensitization screen identifies TP53RK, a kinase that restrains apoptosis after mitotic stress. Cancer Res. 70, 6325\u20136335 (2010).","journal-title":"Cancer Res."},{"key":"71895_CR18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/mi.2017.38","volume":"11","author":"ML Robinette","year":"2018","unstructured":"Robinette, M. L. et al. Jak3 deficiency blocks innate lymphoid cell development. Mucosal Immunol. 11, 50\u201360 (2018).","journal-title":"Mucosal Immunol."},{"key":"71895_CR19","doi-asserted-by":"publisher","first-page":"e0244570","DOI":"10.1371\/journal.pone.0244570","volume":"15","author":"TH Nguyen","year":"2020","unstructured":"Nguyen, T. H., Turek, I., Meehan-Andrews, T., Zacharias, A. & Irving, H. Analysis of interleukin-1 receptor associated kinase-3 (IRAK3) function in modulating expression of inflammatory markers in cell culture models: a systematic review and meta-analysis. PLoS ONE 15, e0244570 (2020).","journal-title":"PLoS ONE"},{"key":"71895_CR20","doi-asserted-by":"publisher","DOI":"10.1172\/JCI161084","volume":"133","author":"G Tunal\u0131","year":"2023","unstructured":"Tunal\u0131, G. et al. Interleukin-1 receptor-associated kinase-3 acts as an immune checkpoint in myeloid cells to limit cancer immunotherapy. J. Clin. Investig. 133, e161084 (2023).","journal-title":"J. Clin. Investig."},{"key":"71895_CR21","doi-asserted-by":"publisher","first-page":"7606","DOI":"10.4049\/jimmunol.181.11.7606","volume":"181","author":"SJ Ramos","year":"2008","unstructured":"Ramos, S. J., Hernandez, J. B., Gatzka, M. & Walsh, C. M. Enhanced T cell apoptosis within Drak2-deficient mice promotes resistance to autoimmunity. J. Immunol. 181, 7606\u20137616 (2008).","journal-title":"J. Immunol."},{"key":"71895_CR22","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.immuni.2004.10.008","volume":"21","author":"MA McGargill","year":"2004","unstructured":"McGargill, M. A., Wen, B. G., Walsh, C. M. & Hedrick, S. M. A deficiency in Drak2 results in a T cell hypersensitivity and an unexpected resistance to autoimmunity. Immunity 21, 781\u2013791 (2004).","journal-title":"Immunity"},{"key":"71895_CR23","doi-asserted-by":"publisher","first-page":"1014508","DOI":"10.3389\/fphar.2022.1014508","volume":"13","author":"Y Zheng","year":"2022","unstructured":"Zheng, Y., Li, X., Kuang, L. & Wang, Y. New insights into the characteristics of DRAK2 and its role in apoptosis: From molecular mechanisms to clinically applied potential. Front. Pharmacol. 13, 1014508 (2022).","journal-title":"Front. Pharmacol."},{"key":"71895_CR24","doi-asserted-by":"publisher","first-page":"112106","DOI":"10.1016\/j.celrep.2023.112106","volume":"42","author":"AH Mandarano","year":"2023","unstructured":"Mandarano, A. H. et al. DRAK2 contributes to type 1 diabetes by negatively regulating IL-2 sensitivity to alter regulatory T cell development. Cell Rep. 42, 112106 (2023).","journal-title":"Cell Rep."},{"key":"71895_CR25","doi-asserted-by":"publisher","first-page":"940","DOI":"10.4049\/jimmunol.1000942","volume":"186","author":"RH Newton","year":"2011","unstructured":"Newton, R. H. et al. Protein kinase D orchestrates the activation of DRAK2 in response to TCR-induced Ca2+ influx and mitochondrial reactive oxygen generation. J. Immunol. 186, 940\u2013950 (2011).","journal-title":"J. Immunol."},{"key":"71895_CR26","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783\u2013784 (2014).","journal-title":"Nat. Methods"},{"key":"71895_CR27","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41392-024-02005-w","volume":"9","author":"S Chen","year":"2024","unstructured":"Chen, S., Zhu, H. & Jounaidi, Y. Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization. Signal Transduct. Target. Ther. 9, 302 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"71895_CR28","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.bbamcr.2011.01.007","volume":"1813","author":"H Huang","year":"2011","unstructured":"Huang, H. & Tindall, D. J. Regulation of FOXO protein stability via ubiquitination and proteasome degradation. Biochim. Biophys. Acta (BBA) - Mol. Cell Res. 1813, 1961\u20131964 (2011).","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Cell Res."},{"key":"71895_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11023","volume":"7","author":"S Wang","year":"2016","unstructured":"Wang, S. et al. FoxO1-mediated autophagy is required for NK cell development and innate immunity. Nat. Commun. 7, 11023 (2016).","journal-title":"Nat. Commun."},{"key":"71895_CR30","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.immuni.2015.02.006","volume":"42","author":"Y Deng","year":"2015","unstructured":"Deng, Y. et al. Transcription factor Foxo1 is a negative regulator of natural killer cell maturation and function. Immunity 42, 457\u2013470 (2015).","journal-title":"Immunity"},{"key":"71895_CR31","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1089\/crispr.2021.0113","volume":"5","author":"D Conant","year":"2022","unstructured":"Conant, D. et al. Inference of CRISPR edits from sanger trace data. CRISPR J. 5, 123\u2013130 (2022).","journal-title":"CRISPR J."},{"key":"71895_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14716","volume":"8","author":"W Yu","year":"2017","unstructured":"Yu, W. et al. Nrl knockdown by AAV-delivered CRISPR\/Cas9 prevents retinal degeneration in mice. Nat. Commun. 8, 14716 (2017).","journal-title":"Nat. Commun."},{"key":"71895_CR33","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201529","volume":"218","author":"R-S Huang","year":"2021","unstructured":"Huang, R.-S., Lai, M.-C., Shih, H.-A. & Lin, S. A robust platform for expansion and genome editing of primary human natural killer cells. J. Exp. Med. 218, e20201529 (2021).","journal-title":"J. Exp. Med."},{"key":"71895_CR34","doi-asserted-by":"publisher","first-page":"E4051","DOI":"10.1073\/pnas.1801340115","volume":"115","author":"W Shang","year":"2018","unstructured":"Shang, W. et al. Genome-wide CRISPR screen identifies FAM49B as a key regulator of actin dynamics and T cell activation. Proc. Natl. Acad. Sci. USA 115, E4051\u2013E4060 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"71895_CR35","doi-asserted-by":"publisher","first-page":"7234","DOI":"10.4049\/jimmunol.0900088","volume":"183","author":"AK Purdy","year":"2009","unstructured":"Purdy, A. K. & Campbell, K. S. SHP-2 expression negatively regulates NK cell function. J. Immunol. 183, 7234\u20137243 (2009).","journal-title":"J. Immunol."},{"key":"71895_CR36","doi-asserted-by":"publisher","first-page":"11115","DOI":"10.1073\/pnas.1406259111","volume":"111","author":"M Giordano","year":"2014","unstructured":"Giordano, M. et al. The tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cells. Proc. Natl. Acad. Sci. USA 111, 11115\u201311120 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"71895_CR37","first-page":"ji2001141","volume":"208","author":"Y Li","year":"2021","unstructured":"Li, Y., Yu, M., Yin, J., Yan, H. & Wang, X. Enhanced calcium signal induces NK cell degranulation but inhibits its cytotoxic activity. J. Immunol. 208, ji2001141 (2021).","journal-title":"J. Immunol."},{"key":"71895_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14714","volume":"8","author":"M Vaeth","year":"2017","unstructured":"Vaeth, M. et al. ORAI2 modulates store-operated calcium entry and T cell-mediated immunity. Nat. Commun. 8, 14714 (2017).","journal-title":"Nat. Commun."},{"key":"71895_CR39","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.180606","volume":"10","author":"Y Baumer","year":"2024","unstructured":"Baumer, Y. et al. Obesity modulates NK-cell activity via LDL & DUSP1 signaling for Populations with Adverse Social Determinants. JCI Insight 10, e180606 (2024).","journal-title":"JCI Insight"},{"key":"71895_CR40","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.jaci.2017.10.040","volume":"142","author":"A Gil-Krzewska","year":"2018","unstructured":"Gil-Krzewska, A. et al. An actin cytoskeletal barrier inhibits lytic granule release from natural killer cells in patients with Chediak-Higashi syndrome. J. Allergy Clin. Immunol. 142, 914\u2013927 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"71895_CR41","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1111\/febs.12836","volume":"281","author":"N Personnic","year":"2014","unstructured":"Personnic, N. et al. A role for Ral GTPase-activating protein subunit \u03b2 in mitotic regulation. FEBS J. 281, 2977\u20132989 (2014).","journal-title":"FEBS J."},{"key":"71895_CR42","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.4049\/jimmunol.1003089","volume":"187","author":"J S\u00e1nchez-Ruiz","year":"2011","unstructured":"S\u00e1nchez-Ruiz, J., Mej\u00edas, R., Garc\u00eda-Belando, M., Barber, D. F. & Gonz\u00e1lez-Garc\u00eda, A. Ral GTPases regulate cell-mediated cytotoxicity in NK cells. J. Immunol. 187, 2433\u20132441 (2011).","journal-title":"J. Immunol."},{"key":"71895_CR43","doi-asserted-by":"publisher","first-page":"10531","DOI":"10.1523\/JNEUROSCI.23-33-10531.2003","volume":"23","author":"MV Khvotchev","year":"2003","unstructured":"Khvotchev, M. V., Ren, M., Takamori, S., Jahn, R. & S\u00fcdhof, T. C. Divergent functions of neuronal Rab11b in Ca2+-regulated versus constitutive exocytosis. J. Neurosci. 23, 10531\u201310539 (2003).","journal-title":"J. Neurosci."},{"key":"71895_CR44","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrm3492","volume":"14","author":"JD Rotty","year":"2013","unstructured":"Rotty, J. D., Wu, C. & Bear, J. E. New insights into the regulation and cellular functions of the ARP2\/3 complex. Nat. Rev. Mol. Cell Biol. 14, 7\u201312 (2013).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"71895_CR45","doi-asserted-by":"publisher","first-page":"e2301","DOI":"10.1038\/cddis.2016.212","volume":"7","author":"L Huang","year":"2016","unstructured":"Huang, L., Zhu, P., Xia, P. & Fan, Z. WASH has a critical role in NK cell cytotoxicity through LCK-mediated phosphorylation. Cell Death Dis. 7, e2301\u2013e2301 (2016).","journal-title":"Cell Death Dis."},{"key":"71895_CR46","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1128\/MCB.01288-12","volume":"33","author":"JT Piotrowski","year":"2013","unstructured":"Piotrowski, J. T., Gomez, T. S., Schoon, R. A., Mangalam, A. K. & Billadeau, D. D. WASH Knockout T cells demonstrate defective receptor trafficking, proliferation, and effector function. Mol. Cell. Biol. 33, 958\u2013973 (2013).","journal-title":"Mol. Cell. Biol."},{"key":"71895_CR47","doi-asserted-by":"publisher","first-page":"10442","DOI":"10.1073\/pnas.0913293107","volume":"107","author":"D Jia","year":"2010","unstructured":"Jia, D. et al. WASH and WAVE actin regulators of the Wiskott\u2013Aldrich syndrome protein (WASP) family are controlled by analogous structurally related complexes. Proc. Natl. Acad. Sci. USA 107, 10442\u201310447 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"71895_CR48","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41586-024-07352-w","volume":"629","author":"M Morotti","year":"2024","unstructured":"Morotti, M. et al. PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function. Nature 629, 426\u2013434 (2024).","journal-title":"Nature"},{"key":"71895_CR49","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/s41590-023-01529-7","volume":"24","author":"VH Wu","year":"2023","unstructured":"Wu, V. H. et al. The GPCR\u2013G\u03b1s\u2013PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure. Nat. Immunol. 24, 1318\u20131330 (2023).","journal-title":"Nat. Immunol."},{"key":"71895_CR50","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.immuni.2020.11.018","volume":"53","author":"NH Knudsen","year":"2020","unstructured":"Knudsen, N. H. & Manguso, R. T. Tumor-derived PGE2 gives NK cells a headache. Immunity 53, 1131\u20131132 (2020).","journal-title":"Immunity"},{"key":"71895_CR51","doi-asserted-by":"publisher","first-page":"e2350635","DOI":"10.1002\/eji.202350635","volume":"54","author":"C Patterson","year":"2024","unstructured":"Patterson, C., Hazime, K. S., Zelenay, S. & Davis, D. M. Prostaglandin E\u2082 impacts multiple stages of the natural killer cell antitumor immune response. Eur. J. Immunol. 54, e2350635 (2024).","journal-title":"Eur. J. Immunol."},{"key":"71895_CR52","doi-asserted-by":"publisher","first-page":"885","DOI":"10.4049\/jimmunol.166.2.885","volume":"166","author":"PC Joshi","year":"2001","unstructured":"Joshi, P. C., Zhou, X., Cuchens, M. & Jones, Q. Prostaglandin E2 suppressed IL-15-mediated human NK cell function through down-regulation of common \u03b3-Chain. J. Immunol. 166, 885\u2013891 (2001).","journal-title":"J. Immunol."},{"key":"71895_CR53","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41586-022-05126-w","volume":"609","author":"J Carnevale","year":"2022","unstructured":"Carnevale, J. et al. RASA2 ablation in T cells boosts antigen sensitivity and long-term function. Nature 609, 174\u2013182 (2022).","journal-title":"Nature"},{"key":"71895_CR54","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00262-011-1064-9","volume":"60","author":"D Holt","year":"2011","unstructured":"Holt, D., Ma, X., Kundu, N. & Fulton, A. Prostaglandin E2 (PGE2) suppresses natural killer cell function primarily through the PGE2 receptor EP4. Cancer Immunol. Immunother. 60, 1577\u20131586 (2011).","journal-title":"Cancer Immunol. Immunother."},{"key":"71895_CR55","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.semcancer.2020.04.003","volume":"67","author":"Y Zhao","year":"2020","unstructured":"Zhao, Y., Xiong, X. & Sun, Y. Cullin-RING Ligase 5: functional characterization and its role in human cancers. Semin. Cancer Biol. 67, 61\u201379 (2020).","journal-title":"Semin. Cancer Biol."},{"key":"71895_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54794-x","volume":"15","author":"Y Adachi","year":"2024","unstructured":"Adachi, Y. et al. Cullin-5 deficiency promotes chimeric antigen receptor T cell effector functions potentially via the modulation of JAK\/STAT signaling pathway. Nat. Commun. 15, 10376 (2024).","journal-title":"Nat. Commun."},{"key":"71895_CR57","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.stem.2020.05.008","volume":"27","author":"H Zhu","year":"2020","unstructured":"Zhu, H. et al. Metabolic reprograming via deletion of CISH in human iPSC-derived NK cells promotes in vivo persistence and enhances anti-tumor activity. Cell Stem Cell 27, 224\u2013237.e6 (2020).","journal-title":"Cell Stem Cell"},{"key":"71895_CR58","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41586-024-07254-x","volume":"629","author":"SB Lacher","year":"2024","unstructured":"Lacher, S. B. et al. PGE2 limits effector expansion of tumour-infiltrating stem-like CD8+ T cells. Nature 629, 417\u2013425 (2024).","journal-title":"Nature"},{"key":"71895_CR59","doi-asserted-by":"publisher","first-page":"e30264","DOI":"10.1371\/journal.pone.0030264","volume":"7","author":"CJ Denman","year":"2012","unstructured":"Denman, C. J. et al. Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells. PLoS ONE 7, e30264 (2012).","journal-title":"PLoS ONE"},{"key":"71895_CR60","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.4420","volume":"12","author":"S Lin","year":"2022","unstructured":"Lin, S., Nguyen, V. & Lin, S. Preparation of Cas9 ribonucleoproteins for genome editing. Bio Protoc. 12, e4420 (2022).","journal-title":"Bio Protoc."},{"key":"71895_CR61","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fimmu.2020.01008","volume":"11","author":"R-S Huang","year":"2020","unstructured":"Huang, R.-S., Shih, H.-A., Lai, M.-C., Chang, Y.-J. & Lin, S. Enhanced NK-92 Cytotoxicity by CRISPR Genome Engineering Using Cas9 Ribonucleoproteins. Front. Immunol. 11, 7\u201316 (2020).","journal-title":"Front. Immunol."},{"key":"71895_CR62","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3390\/cancers13040872","volume":"13","author":"ER Levy","year":"2021","unstructured":"Levy, E. R., Clara, J. A., Reger, R. N., Allan, D. S. J. & Childs, R. W. RNA-Seq analysis reveals CCR5 as a key target for CRISPR gene editing to regulate in vivo NK cell trafficking. Cancers 13, 872 (2021).","journal-title":"Cancers"},{"key":"71895_CR63","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nprot.2017.016","volume":"12","author":"J Joung","year":"2017","unstructured":"Joung, J. et al. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening. Nat. Protoc. 12, 828\u2013863 (2017).","journal-title":"Nat. Protoc."},{"key":"71895_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"Li, W. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 15, 554 (2014).","journal-title":"Genome Biol."},{"key":"71895_CR65","doi-asserted-by":"publisher","first-page":"e246","DOI":"10.1002\/cpz1.246","volume":"1","author":"R Huang","year":"2021","unstructured":"Huang, R., Lai, M. & Lin, S. Ex vivo expansion and CRISPR-Cas9 genome editing of primary human natural killer cells. Curr. Protoc. 1, e246 (2021).","journal-title":"Curr. Protoc."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71895-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71895-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71895-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T01:03:22Z","timestamp":1782176602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71895-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["71895"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-71895-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"25 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5548"}}